Access Management for Transfemoral Transcatheter Aortic Valve Implantation
- 648 Downloads
Transfemoral aortic valve implantation (TAVI) is the most commonly adopted access for TAVI, as vascular injury and complication remain a concern that affects both procedural and clinical outcomes, so meticulous access site selection and preparation, perfect femoral stick, and early complication diagnosis and good management will markedly improve patient’s outcome.
In this chapter, we discuss planning and choice of the vascular access by evaluating the anatomical features of the femoral artery; we highlight the methods of femoral artery access either percutaneously or surgically. Good planning and following best practice for vascular access will reduce the vascular complications.
Predictors and incidence of vascular complication and how they affect the clinical outcome are also discussed; different types of vascular complication and their management are also illustrated.
KeywordsTransfemoral aortic valve implantation TAVI TAVR Vascular access Vascular complication
Dr. Burzotta discloses to have been involved in advisory board meetings or having received speaker’s fees from Medtronic, St Jude Medical, Abiomed, Biotronic. Dr. Trani discloses to have been involved in advisory board meetings or having received speaker’s fees from St Jude Medical, Abiomed, Biotronic.
- 2.Irani F, Kumar S, Colyer WR Jr. Common femoral artery access techniques: a review. J Cardiovasc Med. 2009;10:517–22.Google Scholar
- 5.Johnson LW, Krone R. Cardiac catheterization 1991: a report of the Registry of the Society for Cardiac Angiography and Interventions (SCA&I). Catheter Cardiovasc Diagn. 1993;28:219–20.Google Scholar
- 9.Cole PL, Krone RJ. Approach to reduction of vascular complications of percutaneous valvuloplasty. Catheter Cardiovasc Diagn. 1987;13:331–2.Google Scholar
- 12.Kim D, Orron DE, Skillman JJ, et al. Role of superficial femoral artery puncture in the development of pseudoaneurysm and arteriovenous fistula complicating percutaneous transfemoral cardiac catheterization. Catheter Cardiovasc Diagn. 1992;25:91–7.Google Scholar
- 13.Olasinska-Wisniewska A, Grygier M, Lesiak M, et al. Femoral artery anatomy-tailored approach in transcatheter aortic valve implantation. Adv Interv Cardiol. 2017;13:150–6.Google Scholar
- 20.Burzotta F, Paloscia L, Trani C, et al. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study. J Cardiovasc Med. 2008;9:1004–10.Google Scholar
- 26.Garcia E, Martin-Hernandez P, Unzue L, Hernandez-Antolin RA, Almeria C, Cuadrado A. Usefulness of placing a wire from the contralateral femoral artery to improve the percutaneous treatment of vascular complications in TAVI. Revista Esp Cardiol. 2014;67:410–2.Google Scholar
- 46.Dzijan-Horn M, Langwieser N, Groha P, et al. Safety and efficacy of a potential treatment algorithm by using manual compression repair and ultrasound-guided thrombin injection for the management of iatrogenic femoral artery pseudoaneurysm in a large patient cohort. Circ Cardiovasc Interv. 2014;7:207–15.PubMedGoogle Scholar
- 63.Fanaroff AC, Manandhar P, Holmes DR, et al. Peripheral artery disease and transcatheter aortic valve replacement outcomes: a report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Therapy Registry. Circ Cardiovasc Interv. 2017;10:e005456.PubMedPubMedCentralGoogle Scholar